ClinicalTrials.govpublic full text
Induction Chemoimmunotherapy Followed by Deescalated Definitive Radiotherapy in Head and Neck Cancer
head and neck squamous cell carcinoma, locally advanced head and neck cancer, hnscc, induction chemoimmunotherapy, de-escalated radiotherapy, camrelizumab, pd-1 inhibitor, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 868738
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.